Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
11.87
+0.55 (4.86%)
At close: Mar 9, 2026, 4:00 PM EDT
12.10
+0.23 (1.94%)
After-hours: Mar 9, 2026, 6:57 PM EDT
Xencor Market Cap
Xencor has a market cap or net worth of $870.53 million as of March 9, 2026. Its market cap has decreased by -20.97% in one year.
Market Cap
870.53M
Enterprise Value
334.94M
1-Year Change
-20.97%
Ranking
Category
Stock Price
$11.87
Market Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $870.53M, an increase of 254.74%. That is a compound annual growth rate of 10.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 870.50M | -20.38% |
| Dec 31, 2025 | 1.09B | -32.02% |
| Dec 31, 2024 | 1.61B | 24.44% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arvinas | 869.87M |
| Janux Therapeutics | 841.91M |
| Phathom Pharmaceuticals | 840.78M |
| Sana Biotechnology | 840.63M |
| Evommune | 835.39M |
| BridgeBio Oncology Therapeutics | 833.48M |
| KalVista Pharmaceuticals | 820.37M |
| Omeros | 818.19M |